An advisory panel for the U.S. Federal Drug Administration (F.D.A.) voted 19-3 to recommend the use of Truvada, a combination antiretroviral drug, for the prevention of HIV among people at high risk of infection. Although this is not a full F.D.A. approval, it paves the way for a decision in mid-June. The endorsement follows a […]